BeiGene (BGNE) Misses Q3 EPS by 26c

BeiGene (NASDAQ: BGNE) reported Q3 EPS of ($1.08), $0.26 worse than the analyst estimate of ($0.82).

Cash, Cash Equivalents, and Short-term Investments were $203.62 million as of September 30, 2016, compared to $100.49 million as of December 31, 2015. The increase reflects net initial public offering (IPO) proceeds received in the first quarter of 2016, partially offset by cash used in operating activities for the nine months ended September 30, 2016.

For earnings history and earnings-related data on BeiGene (BGNE) click here.

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• Deutsche Bank (DB) Tops Q1 EPS by 1c
• First Merchants Corp (FRME) Tops Q1 EPS by 3c